propafenone has been researched along with Ventricular Dysfunction in 3 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flecainide and propafenone are antiarrhythmic drugs of the class 1C (Vaughan and Williams) commonly used for ventricular arrhythmias." | 10.17 | [Propafenone and flecainide in the therapy of ventricular arrhythmias]. ( Davini, A; Lattanzi, F; Paci, A; Paperini, L; Reisenhofer, B; Squarcini, G; Topi, A; Topi, PL, 1995) |
| "Propafenone is a sodium channel blocking antiarrhythmic drug." | 6.39 | Propafenone: an effective agent for the management of supraventricular arrhythmias. ( Grant, AO, 1996) |
| "Flecainide and propafenone are antiarrhythmic drugs of the class 1C (Vaughan and Williams) commonly used for ventricular arrhythmias." | 6.17 | [Propafenone and flecainide in the therapy of ventricular arrhythmias]. ( Davini, A; Lattanzi, F; Paci, A; Paperini, L; Reisenhofer, B; Squarcini, G; Topi, A; Topi, PL, 1995) |
| "Propafenone is a sodium channel blocking antiarrhythmic drug." | 2.39 | Propafenone: an effective agent for the management of supraventricular arrhythmias. ( Grant, AO, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pavoni, D | 1 |
| Ragazzo, S | 1 |
| Driussi, M | 1 |
| Antonini-Canterin, F | 1 |
| Pavan, D | 1 |
| Zardo, F | 1 |
| Nicolosi, GL | 1 |
| Grant, AO | 1 |
| Paperini, L | 1 |
| Davini, A | 1 |
| Lattanzi, F | 1 |
| Topi, A | 1 |
| Reisenhofer, B | 1 |
| Squarcini, G | 1 |
| Paci, A | 1 |
| Topi, PL | 1 |
2 reviews available for propafenone and Ventricular Dysfunction
| Article | Year |
|---|---|
Propafenone: an effective agent for the management of supraventricular arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Propafenone; Tachycardia, Supraventri | 1996 |
[Propafenone and flecainide in the therapy of ventricular arrhythmias].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Drug Evaluation; | 1995 |
1 trial available for propafenone and Ventricular Dysfunction
| Article | Year |
|---|---|
[Propafenone and flecainide in the therapy of ventricular arrhythmias].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Drug Evaluation; | 1995 |
1 other study available for propafenone and Ventricular Dysfunction
| Article | Year |
|---|---|
Transient platypnea-orthodeoxia-like syndrome induced by propafenone overdose in a young woman with Ebstein's anomaly.
Topics: Adult; Anti-Arrhythmia Agents; Cyanosis; Dose-Response Relationship, Drug; Ebstein Anomaly; Echocard | 2003 |